Journal of Clinical and Cellular Immunology
Open Access

ISSN: 2155-9899

Journal of Clinical and Cellular Immunology : Citations & Metrics Report

Articles published in Journal of Clinical and Cellular Immunology have been cited by esteemed scholars and scientists all around the world. Journal of Clinical and Cellular Immunology has got h-index 42, which means every article in Journal of Clinical and Cellular Immunology has got 42 average citations.

Following are the list of articles that have cited the articles published in Journal of Clinical and Cellular Immunology.

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Total published articles	30	31	30	59	28	11	35	56	95	105	101	105	64	15	3
Research, Review articles and Editorials	2	13	8	23	18	8	25	35	54	86	79	35	23	14	3
Research communications, Review communications, Editorial communications, Case reports and Commentary	20	18	22	22	10	3	10	21	39	6	9	7	1	1	0
Conference proceedings	0	16	15	6	0	98	178	206	171	160	195	156	74	0	0
Citations received as per Google Scholar, other indexing platforms and portals	653	826	931	1079	1018	971	871	851	753	550	276	145	43	40	0

Journal total citations count	8361
Journal impact factor	24.12
Journal 5 years impact factor	31.14
Journal cite score	30.45
Journal h-index	42
Journal h-index since 2019	32

Important citations (1511)

pellom jr st, dudimah df, thounaojam mc, sayers tj, shanker a (2015) modulatory effects of bortezomib on host immune cell functions. immunotherapy 7: 1011-1022. View at Publisher View at Google Scholar
han b, yao w, oh yt, tong js, li s, et al. (2015) the novel proteasome inhibitor carfilzomib activates and enhances extrinsic apoptosis involving stabilization of death receptor 5. oncotarget 6: 17532-17542. View at Publisher View at Google Scholar
knoff j, yang b, hung cf, wu tc (2014) cervical cancer: development of targeted therapies beyond molecular pathogenesis. curr obst gynecol rep 3: 18-32. View at Publisher View at Google Scholar
’t hart ba, kap ys (2017). an essential role of virus-infected b cells in the marmoset experimental autoimmune encephalomyelitis model. multiple sclerosis journal–experimental, translational and clinical. 3:2055217317690184. View at Publisher View at Google Scholar
micale n, scarbaci k, troiano v, ettari r, grasso s, et al. (2014) peptideâ€based proteasome inhibitors in anticancer drug design. med res rev 34: 1001-1069. View at Publisher View at Google Scholar
bhave m, akhter n, rosen st (2014) cardiovascular toxicity of biologic agents for cancer therapy. oncology 28: 482. View at Publisher View at Google Scholar
zhang x, li w, wang c, leng x, lian s, et al. (2014) inhibition of autophagy enhances apoptosis induced by proteasome inhibitor bortezomib in human glioblastoma u87 and u251 cells. mol cell biochem 385: 265-275. View at Publisher View at Google Scholar
ji x, zhang l, peng j, hou m (2014) t cell immune abnormalities in immune thrombocytopenia. j hematol oncol 7: 72. View at Publisher View at Google Scholar
furfaro al, piras s, passalacqua m, domenicotti c, parodi a, et al. (2014) ho-1 up-regulation: a key point in high-risk neuroblastoma resistance to bortezomib. biochimica et biophysica acta (bba)-molecular basis of disease 1842: 613-622. View at Publisher View at Google Scholar
lee cy, lin cc, liu yl, liu gy, liu jh, et al. (2017) molecular interplay between the dimer interface and the substrate-binding site of human peptidylarginine deiminase 4. scientific reports. 7:42662. View at Publisher View at Google Scholar
lee gy, haverty pm, li l, kljavin nm, bourgon r, et al. (2014) comparative oncogenomics identifies psmb4 and shmt2 as potential cancer driver genes. can res 74: 3114-3126. View at Publisher View at Google Scholar
Wojcik s (2013) crosstalk between autophagy and proteasome protein degradation systems: possible implications for cancer therapy. folia histochem cytobiol 51: 249-264. View at Publisher View at Google Scholar
wojcik s (2013) crosstalk between autophagy and proteasome protein degradation systems: possible implications for cancer therapy. folia histochem cytobiol 51: 249-264. View at Publisher View at Google Scholar
Schmidt j, braggio e, kortuem km, egan jb, zhu yx, et al. (2013) genome-wide studies in multiple myeloma identify xpo1/crm1 as a critical target validated using the selective nuclear export inhibitor kpt-276. leukemia 27: 2357-2365. View at Publisher View at Google Scholar
mai sh. in vivo studies of cell-free dna and dnase in a murine model of polymicrobial sepsis (doctoral dissertation). View at Publisher View at Google Scholar
pahan k (2013). multiple sclerosis and experimental allergic encephalomyelitis. jcci sep 23:4. View at Publisher View at Google Scholar
Richardson cd (2016) pvrl4 (nectin4) is a receptor for measles virus. united states patent. View at Publisher View at Google Scholar
Earla p (2014) ancient diseases-microbial impact. j anc dis prev rem. View at Publisher View at Google Scholar
The level of igg antibodies reactive to tf, tn and alpha-gal polyacrylamide-glycoconjugates in breast cancer patients: relation to survival View at Publisher View at Google Scholar View at Indexing
smorodin ep, sergeyev bl, kurtenkov oa (2014) the characterization of igg antibodies to galnac beta-terminated glycans of gastric cancer survivors. exp oncol 36: 38-43. View at Publisher View at Google Scholar
Prev 1 2 ... 47 48 49 50 51 52 53 54 55 56 57 ... 75 76 Next »

Top